Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Dermatoscopy helps diagnose hair and scalp disorders in people with Afro-textured hair, but more research is needed for better understanding and treatment.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

Frontal fibrosing alopecia can mimic traction alopecia but has distinct features like facial papules and eyebrow thinning.

Wearing a wig caused a woman's skin condition to worsen due to pressure from the wig's fasteners.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Sensitive skin is often caused by nerve fibers and environmental factors, and can be managed with mild skincare and professional advice.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Type I interferons play a key role in the development of various skin diseases.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

A woman with EMS showed unusual skin mucinosis without the typical hard skin syndrome, suggesting EMS can cause skin mucinosis.